NO984007L - Nye disubstituerte trans-3,4,4a,5,6,10b-heksahydro-2H-naft[1,2-b]-1,4-oksaziner, en fremgangsmÕte ved deres fremstilling og farmas°ytiske sammensetninger inneholder disse - Google Patents

Nye disubstituerte trans-3,4,4a,5,6,10b-heksahydro-2H-naft[1,2-b]-1,4-oksaziner, en fremgangsmÕte ved deres fremstilling og farmas°ytiske sammensetninger inneholder disse

Info

Publication number
NO984007L
NO984007L NO984007A NO984007A NO984007L NO 984007 L NO984007 L NO 984007L NO 984007 A NO984007 A NO 984007A NO 984007 A NO984007 A NO 984007A NO 984007 L NO984007 L NO 984007L
Authority
NO
Norway
Prior art keywords
oxazines
hexahydro
naphth
preparation
pharmaceutical compositions
Prior art date
Application number
NO984007A
Other languages
English (en)
Other versions
NO311218B1 (no
NO984007D0 (no
Inventor
Jean-Louis Peglion
Jean-Christophe Harmange
Mark Millan
Francoise Lejeune
Original Assignee
Adir
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adir filed Critical Adir
Publication of NO984007D0 publication Critical patent/NO984007D0/no
Publication of NO984007L publication Critical patent/NO984007L/no
Publication of NO311218B1 publication Critical patent/NO311218B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/34—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Medicinal Chemistry (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Anesthesiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO19984007A 1997-09-01 1998-08-31 Nye disubstituerte trans-3,4,4a,5,6,10b-heksahydro-2H- naft[1,2-b]-1,4-oksaziner, en fremgangsmåte ved deres fremstillingog farmasöytiske sammensetninger inneholder disse NO311218B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9710852A FR2767825A1 (fr) 1997-09-01 1997-09-01 Nouvelles trans-3,4,4a,5,6,10b-hexahydro-2h-napht°1,2-b!-1, 4-oxazines disubstituees, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Publications (3)

Publication Number Publication Date
NO984007D0 NO984007D0 (no) 1998-08-31
NO984007L true NO984007L (no) 1999-03-02
NO311218B1 NO311218B1 (no) 2001-10-29

Family

ID=9510643

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19984007A NO311218B1 (no) 1997-09-01 1998-08-31 Nye disubstituerte trans-3,4,4a,5,6,10b-heksahydro-2H- naft[1,2-b]-1,4-oksaziner, en fremgangsmåte ved deres fremstillingog farmasöytiske sammensetninger inneholder disse

Country Status (19)

Country Link
US (1) US6025356A (no)
EP (1) EP0899267B1 (no)
JP (1) JP4417451B2 (no)
CN (1) CN1088064C (no)
AT (1) ATE229513T1 (no)
AU (1) AU740928C (no)
BR (1) BR9803933A (no)
CA (1) CA2246482C (no)
DE (1) DE69810034T2 (no)
DK (1) DK0899267T3 (no)
ES (1) ES2189108T3 (no)
FR (1) FR2767825A1 (no)
HK (1) HK1020340A1 (no)
HU (1) HU226059B1 (no)
NO (1) NO311218B1 (no)
NZ (1) NZ331637A (no)
PL (1) PL194533B1 (no)
PT (1) PT899267E (no)
ZA (1) ZA987963B (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0130219D0 (en) * 2001-12-18 2002-02-06 Pfizer Ltd Compounds for the treatment of sexual dysfunction
WO2004019889A2 (en) * 2002-08-30 2004-03-11 Biostratum, Inc. Inhibitors of post-amadori advanced glycation end products
BRPI0409492A (pt) * 2003-04-18 2006-05-02 Pharmacia & Up John Company Ll terapias de combinação
FR2906249B1 (fr) * 2006-09-26 2008-12-19 Servier Lab Composes tetracycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
EP2098511A1 (en) 2008-03-07 2009-09-09 Solvias AG Process for preparing compounds containing a hydronaphtalene structure with an unsymmetrically substituted benzene ring
JP2011525893A (ja) * 2008-06-27 2011-09-29 ハー・ルンドベック・アクチエゼルスカベット 新規のフェノールアミン類およびカテコールアミン類ならびにそのプロドラッグ

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4420480A (en) * 1981-11-20 1983-12-13 Merck & Co., Inc. Hexahydronaphth[1,2-b]-1,4-oxazines
CA1204745A (en) * 1981-11-20 1986-05-20 Merck Co. Hexahydronaphth (1,2-b) -1,4 -oxazines
US4540691A (en) * 1984-04-13 1985-09-10 Nelson Research & Development Co. Dopamine agonists and use thereof
US5486611A (en) * 1989-07-13 1996-01-23 The Upjohn Company Carboxamido-(1,2N)-carbocyclic-2-aminotetralin derivatives
JPH05508408A (ja) * 1990-06-15 1993-11-25 ホイツトビー・リサーチ・インコーポレーテツド ドーパミン作動性薬剤として有用な置換ナフトキサジン類

Also Published As

Publication number Publication date
DE69810034D1 (de) 2003-01-23
AU740928C (en) 2002-05-16
PL328285A1 (en) 1999-03-15
AU8302498A (en) 1999-03-11
NO311218B1 (no) 2001-10-29
PL194533B1 (pl) 2007-06-29
HUP9801951A3 (en) 2000-04-28
FR2767825A1 (fr) 1999-02-26
CA2246482A1 (fr) 1999-03-01
HK1020340A1 (en) 2000-04-14
JP4417451B2 (ja) 2010-02-17
AU740928B2 (en) 2001-11-15
NZ331637A (en) 1999-07-29
NO984007D0 (no) 1998-08-31
CN1222516A (zh) 1999-07-14
DE69810034T2 (de) 2003-08-14
PT899267E (pt) 2003-04-30
BR9803933A (pt) 2001-04-24
JPH11130759A (ja) 1999-05-18
HU9801951D0 (en) 1998-11-30
ES2189108T3 (es) 2003-07-01
CN1088064C (zh) 2002-07-24
HU226059B1 (en) 2008-04-28
HUP9801951A2 (hu) 2000-02-28
EP0899267B1 (fr) 2002-12-11
ATE229513T1 (de) 2002-12-15
EP0899267A1 (fr) 1999-03-03
ZA987963B (en) 1999-03-04
DK0899267T3 (da) 2003-03-10
CA2246482C (fr) 2002-11-26
US6025356A (en) 2000-02-15

Similar Documents

Publication Publication Date Title
NO972510L (no) Nye benzisoksazol-forbindelser, fremgangsmåter ved deres fremstilling og farmasöytiske sammensetninger inneholdede dem
HU9600278D0 (en) Remedy for nervous diseases
PT91417A (pt) Processo para a preparacao de derivados indolicos
DK0648771T3 (da) Galanthamin-derivat, en fremgangsmåde til dets fremstilling og dets anvendelse som medikament
NO984007L (no) Nye disubstituerte trans-3,4,4a,5,6,10b-heksahydro-2H-naft[1,2-b]-1,4-oksaziner, en fremgangsmÕte ved deres fremstilling og farmas°ytiske sammensetninger inneholder disse
AU5473596A (en) New indole, indazole benzisoxazole compounds, their process of preparation and the pharmaceutical compositions which contain them
NO20000373L (no) Nye cyano-indol serotinin-reopptaks-inhibitorforbindelser, fremgangsmÕte for deres fremstilling og farmasøytiske sammensetninger inneholdende dem
NO964672L (no) Nye tetracykliske 1,4-oksazinforbindelser, fremgangsmåter ved deres fremstilling og farmasöytiske sammensetninger innholdende dem
NO972943L (no) 4-amino-2-ureido-pyrimidin-5-karboksylsyreamider, fremgangsmåter for deres fremstilling, legemidler inneholdende dem og deres anvendelse
FI952802A (fi) Uudet tetrasykliset piperidiini- ja 1,4-oksatsiiniyhdisteet, menetelmä niiden valmistamiseksi ja niitä sisältävät farmaseuttiset koostumukset
NO303494B1 (no) Tetrahydronaftalenderivater, fremgangsmÕte for deres fremstilling og farmas°ytisk preparat inneholdende et slikt derivat, samt mellomprodukter
DK0673934T3 (da) Aminoalkylbenzothiazolinoner, fremgangsmåde til fremstilling af sådanne forbindelser og farmaceutiske sammensætninger indeholdende disse
NO996285D0 (no) Nye spiroimidazolinforbindelser, fremgangsmåte ved deres fremstilling og farmasoeytiske sammensetninger inneholdende dem

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees